Key result
Severe calcific AS is linked to ~2,950 differentially expressed genes involving immune response and adipocyte metabolism.
Why the study?
There is currently no medical therapy for calcific aortic valve stenosis, motivating the identification of transcriptomic signatures of disease severity.
Observational (n=486)
No
Answers are grounded in this paper and cite their sources.
Transcriptomic analysis of explanted human aortic valves reveals that immune response, inflammation, and adipocyte metabolism are key pathways in calcific aortic valve stenosis severity, identifying potential targets for pharmacological treatment.
There is currently no medical therapy for calcific aortic valve stenosis. We aimed to identify transcriptomic signatures of the disease severity. We performed mRNA sequencing from explanted human aortic valves of 500 individuals who underwent aortic valve replacement (n = 440) or a heart transplant (n = 60). We performed differential gene expression analyses according to hemodynamic severity, valve morphology, calcification grade, and age of onset, and we estimated immune cell proportions. We identified immune response, inflammation, and adipocyte metabolism as predominant pathways associated with calcific aortic valve stenosis severity, offering new perspectives for the development of pharmacological treatments.
No takes yet. Share an insight, caveat, or question.
Houessou et al. (2025) conducted an observational in Calcific aortic valve stenosis (n=486). Severe calcific aortic valve stenosis vs. Mild or no calcific aortic valve stenosis was evaluated on Differentially expressed genes (|FC| > 1.5) (p=<0.05). Severe calcific aortic valve stenosis was associated with 2,951 differentially expressed genes compared to mild or no stenosis, highlighting the predominant involvement of immune response and adipocyte metabolism.
Synapse has enriched 10 related papers. Consider them for comparative context: